Clinical trial
Study In Patients With Type 2 Diabetes Who Are Taking Metformin And…
NCT00269061 · GlaxoSmithKline, Industry · Completed
Key facts
| NCT number | NCT00269061 |
|---|---|
| Title | Study In Patients With Type 2 Diabetes Who Are Taking Metformin And Sulfonylurea, Metformin And Insulin, Or Insulin |
| Official title | An Exploratory MRI Study in Type 2 Diabetic Subjects: A Randomized, Double-Blinded, Placebo-Controlled Trial to Evaluate the Measurement of Fluid Volumes by MRI in the Lower Extremities of Subjects Receiving Pioglitazone |
| Lead sponsor | GlaxoSmithKline, Industry |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Non-Insulin-Dependent Diabetes Mellitus |
| Intervention type | Drug |
| Interventions | pioglitazone |
| Enrollment | 32 |
| Start date | Jan 1, 2006 |
| First posted | Dec 23, 2005 |
| Last update posted | Oct 16, 2008 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: